IL10 and neoplasm: CCL18 also influences DC fate by attracting immature DCs to the tumour niche, where they differentiate into tumour-associated DCs (TADCs) [273,278], which produce immunosuppressive IL-10 and indoleamine 2,3-dioxygenase (IDO) (Figure 3) [279], further expanding Tregs.